Part 4: Today’s Most Promising Drug Targets
43 Experts Weigh in on the Most Promising Disease-Modifying Therapies in PD
All posts tagged: Druggable
Part 3: A Crash Course in Drug Development
The Most Important Hurdles To Getting a Drug to Market
Interview with Biochemist and LRRK2 Expert Prof. Dario Alessi
on the Fundamental Limitations of our Understanding of Biology, the Development of LRRK2 Inhibitors, and more
